RE:Valeant Drug Sale... Just Down the StreetValeant is going to sell over $8 billion US of its non core drugs in order to pay down debt.
These include a wide suite of both US and Canadian drugs and presents TST with a unique opportunity to acquire a suite of these drugs either singly or by merger or by RTO.
Valeant is HQed in Lavalle Quebec.
Buy and hold as we are going to see developments before the end of Sept